Despite significant progress in the pathogenesis, diagnosis, treatment, and prevention of cancer and neurodegenerative diseases, their occurrence and mortality are still high around the world. The resistance of cancer cells to the drugs remains a significant problem in oncology today, while in the case of neuro-degenerative diseases, therapies reversing the process are still yet to be found. Furthermore, it is important to seek new chemotherapeutics reversing side effects of currently used drugs or helping them perform their function to inhibit progression of the disease. Carnosine, a dipeptide constisting of β-alanine and l-histidine, has a variety of functions to mention: antioxidant, antiglycation, and reducing the toxicity of metal ions. It has therefore been proposed to act as a therapeutic agent for many pathological states. The aim of this paper was to find if carnosine and its derivatives can be helpful in treating various diseases. Literature search presented in this review includes review and original papers found in SciFinder, PubMed, and Google Scholar. Searches were based on substantial keywords concerning therapeutic usage of carnosine and its derivatives in several diseases including neurodegenerative disorders and cancer. In this paper, we review articles and find that carnosine and its derivatives are potential therapeutic agents in many diseases including cancer, neurodegenerative diseases, diabetes, and schizophrenia. Carnosine and its derivatives can be used in treating neurodegenerative diseases, cancer, diabetes, or schizophrenia, although their usage is limited. Therefore, there's an urge to synthesize and analyze new substances, overcoming the limitation of carnosine itself.

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.chemrestox.0c00010DOI Listing

Publication Analysis

Top Keywords

carnosine derivatives
20
neurodegenerative diseases
12
diseases
8
cancer neurodegenerative
8
find carnosine
8
diseases including
8
diabetes schizophrenia
8
carnosine
7
derivatives
5
cancer
5

Similar Publications

Cluster Headache and Hypoxia: Breathing New Life into an Old Theory, with Novel Implications.

Neurol Int

December 2024

Department of Psychology, University of Maine, 301 Williams Hall, Orono, ME 04469-5742, USA.

Cluster headache is a severe, poorly understood disorder for which there are as yet virtually no rationally derived treatments. Here, Lee Kudrow's 1983 theory, that cluster headache is an overly zealous response to hypoxia, is updated according to current understandings of hypoxia detection, signaling, and sensitization. It is shown that the distinctive clinical characteristics of cluster headache (circadian timing of attacks and circannual patterning of bouts, autonomic symptoms, and agitation), risk factors (cigarette smoking; male gender), triggers (alcohol; nitroglycerin), genetic findings (GWAS studies), anatomical substrate (paraventricular nucleus of the hypothalamus, solitary tract nucleus/NTS, and trigeminal nucleus caudalis), neurochemical features (elevated levels of galectin-3, nitric oxide, tyramine, and tryptamine), and responsiveness to treatments (verapamil, lithium, melatonin, prednisone, oxygen, and histamine desensitization) can all be understood in terms of hypoxic signaling.

View Article and Find Full Text PDF

Purpose: Identifying the determinants of performance is fundamental to talent identification and individualizing training prescription. Consequently, the aim of this study was to determine whether estimated muscle typology is associated with the key mechanical characteristics of track sprint cycling.

Methods: Sixteen world-class and elite track cyclists (n = 7 female) completed a laboratory session wherein torque-cadence and power-cadence profiles were constructed to determine maximal power output (Pmax), optimal cadence (Fopt), and maximal cadence (Fmax), and fatigue rate per pedal stroke was determined during a 15-second maximal sprint at Fopt.

View Article and Find Full Text PDF

Exercise alleviates hematopoietic stem cell injury following radiation via the carnosine/Slc15a2-p53 axis.

Cell Commun Signal

December 2024

State Key Laboratory of Trauma and Chemical Poisoning, Institute of Combined Injury, Chongqing Engineering Research Center for Nanomedicine, College of Preventive Medicine, Third Military Medical University, Chongqing, 400038, China.

Article Synopsis
  • Ionizing radiation (IR) can damage hematopoietic stem cells (HSCs), causing myelosuppression, but the protective effects of moderate exercise against this damage are still being studied.
  • This research shows that long-term moderate exercise helps protect HSCs from IR injury by generating carnosine in skeletal muscles, which supports HSC function and reduces bone marrow damage.
  • Carnosine, transported to HSCs via a specific mechanism, inhibits the activity of the p53 protein, leading to enhanced HSC survival and proliferation after IR exposure—suggesting that exercise or carnosine supplementation could be beneficial strategies against IR-related damage.
View Article and Find Full Text PDF

-Lactoyl-phenylalanine (Lac-Phe) is a metabolite known for its appetite-suppressing and antiobesity properties, while phenyllactic acid (PLA) is recognized for its antibacterial activity. Both metabolites are derived from phenylalanine and lactic acid metabolism through peptidase and dehydrogenase activities. The aim of this study was to investigate the production of Lac-Phe and PLA in kimchi, focusing on the role of lactic acid bacteria (LAB).

View Article and Find Full Text PDF

Imidazole dipeptides (IDPs) are found in the skeletal muscles and brains of various animals, and they exhibit unique functions like antioxidant and antiaging properties. Despite their importance, the metabolic mechanisms and physiological roles of IDPs remain unclear. Herein, we propose a method for the simultaneous analysis of IDPs, their constituent amino acids, and taurine, which are difficult to separate using conventional labeling reagents or columns, using liquid chromatography-single quadrupole mass spectrometry with PBr column and our highly sensitive labeling reagent, 1-fluoro-2,4-dinitrophenyl-5-l-valine-,-dimethylethylenediamineamide (l-FDVDA).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!